Variations in pain prevalence, severity, and analgesic use by duration of survivorship: a cross-sectional study of 505 post-treatment head and neck cancer survivors
العنوان: | Variations in pain prevalence, severity, and analgesic use by duration of survivorship: a cross-sectional study of 505 post-treatment head and neck cancer survivors |
---|---|
المؤلفون: | Jenny L. Ren, Raniv D. Rojo, Joy Vanessa D. Perez, Sai-Ching J. Yeung, Ehab Y. Hanna, Cielito C. Reyes-Gibby |
المصدر: | BMC Cancer BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021) |
سنة النشر: | 2021 |
مصطلحات موضوعية: | Adult, Aged, 80 and over, Male, Cancer Research, Analgesics, Research, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Pain, Survivorship, Middle Aged, Opioids, Young Adult, Cross-Sectional Studies, Oncology, Head and Neck Neoplasms, Genetics, Prevalence, Quality of Life, Humans, Female, Head and neck cancer, RC254-282, Aged |
الوصف: | Background Studies suggest a high prevalence of pain in head and neck cancer (HNC) patients at diagnosis, during and after treatment; however, these studies had small sample sizes and did not comprehensively assess factors known to influence pain. We surveyed a large cohort of HNC survivors to determine variations in the prevalence of pain, its treatment and management by duration of survivorship, and assessed a comprehensive list of risk factors. Methods A cross sectional survey of post-treatment survivors of HNC during routine follow-up clinic visits. Results A total of 505 HNC survivors with a median follow up of 3 years from cancer diagnosis were included in the study. Overall, 45% (n = 224) reported pain and 14.5, 22 and 7% reported use of prescribed pain medication, over-the-counter pain medication and alternative pain therapies, respectively. Prevalence of severe pain was 7.3% and did not vary significantly by years of survivorship (P = 0.392). However, use of prescribed pain medication significantly varied by years of survivorship (p p Conclusions We identified a high prevalence of pain among HNC survivors and determined that analgesic use varied by the duration of survivorship. Therefore, routine surveillance for pain must be consistent throughout the course of survivorship. |
تدمد: | 1471-2407 |
الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dd11227e9dd5f4a6e1f7afc0ebf62e0Test https://pubmed.ncbi.nlm.nih.gov/34872526Test |
حقوق: | OPEN |
رقم الانضمام: | edsair.doi.dedup.....4dd11227e9dd5f4a6e1f7afc0ebf62e0 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 14712407 |
---|